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ß-defensins are antimicrobial peptides secreted by epithe-
lial cells that can bind to cellular receptors. CCR2 and
CCR6 are the two cellular receptors known to bind
human ß-defensin (hBD) 2 and -3. Both of these recep-
tors are of crucial relevance in HIV infection. CCR6 is
expressed, often in concert with CCR5, on cells that are
highly susceptible to HIV infection: memory T cells, Th17
cells, a4ß7
+ cells, and defects in CD4
+CCR6
+ cells have
been associated with faster AIDS progression. CCR2 is
expressed on monocytes and macrophages, cells that are
reservoirs of HIV infection and that are known to med-
iate central nervous system damage. Our studies show
that hBD2, hBD3, and CCR6 ligand MIP-3a/CCL20 inhi-
bit HIV infection via CCR6 by increasing expression of
the antiviral protein APOBEC3G. This increase is due to
a transcriptional mechanism mediated by intracellular
signaling. hBD2 also inhibits HIV replication in macro-
phages that express CCR2. Our findings suggest novel
therapeutic and preventive approaches that exploit CCR6
and CCR2-mediated intracellular signaling to inhibit HIV
infection in highly susceptible cells.
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